170 related articles for article (PubMed ID: 16728546)
1. Potential advantage of N363S glucocorticoid receptor polymorphism in 21-hydroxylase deficiency.
Luczay A; Török D; Ferenczi A; Majnik J; Sólyom J; Fekete G
Eur J Endocrinol; 2006 Jun; 154(6):859-64. PubMed ID: 16728546
[TBL] [Abstract][Full Text] [Related]
2. A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Coeli-Lacchini FB; Turatti W; Elias PC; Elias LL; Martinelli CE; Moreira AC; Antonini SR; de Castro M
Gene; 2013 Sep; 526(2):239-45. PubMed ID: 23570880
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of the CYP21 gene and prenatal diagnosis in families with 21-hydroxylase deficiency in northeastern Iran.
Vakili R; Baradaran-Heravi A; Barid-Fatehi B; Gholamin M; Ghaemi N; Abbaszadegan MR
Horm Res; 2005; 63(3):119-24. PubMed ID: 15775714
[TBL] [Abstract][Full Text] [Related]
4. Hyperandrogenism in carriers of CYP21 mutations: the role of genotype.
Admoni O; Israel S; Lavi I; Gur M; Tenenbaum-Rakover Y
Clin Endocrinol (Oxf); 2006 Jun; 64(6):645-51. PubMed ID: 16712666
[TBL] [Abstract][Full Text] [Related]
5. Mutational spectrum of steroid 21-hydroxylase and the genotype-phenotype association in Middle European patients with congenital adrenal hyperplasia.
Dolzan V; Sólyom J; Fekete G; Kovács J; Rakosnikova V; Votava F; Lebl J; Pribilincova Z; Baumgartner-Parzer SM; Riedl S; Waldhauser F; Frisch H; Stopar-Obreza M; Krzisnik C; Battelino T
Eur J Endocrinol; 2005 Jul; 153(1):99-106. PubMed ID: 15994751
[TBL] [Abstract][Full Text] [Related]
6. [CYP21 gene point mutations study in 21-hydroxylase deficiency patients].
Liao XY; Zhang YF; Gu XF
Zhonghua Er Ke Za Zhi; 2003 Sep; 41(9):670-4. PubMed ID: 14733808
[TBL] [Abstract][Full Text] [Related]
7. The frequency of CYP 21 gene mutations in Turkish women with hyperandrogenism.
Kelestimur F; Everest H; Dundar M; Tanriverdi F; White C; Witchel SF
Exp Clin Endocrinol Diabetes; 2009 May; 117(5):205-8. PubMed ID: 19085698
[TBL] [Abstract][Full Text] [Related]
8. Functional glucocorticoid receptor gene variants do not underlie the high variability of 17-hydroxyprogesterone screening values in healthy newborns.
Schreiner F; Tozakidou M; Maslak R; Holtkamp U; Peter M; Gohlke B; Woelfle J
Eur J Endocrinol; 2009 Apr; 160(4):667-73. PubMed ID: 19174530
[TBL] [Abstract][Full Text] [Related]
9. Association between genotype, clinical presentation, and severity of congenital adrenal hyperplasia: a review.
Al-Agha AE; Ocheltree AH; Al-Tamimi MD
Turk J Pediatr; 2012; 54(4):323-32. PubMed ID: 23692712
[TBL] [Abstract][Full Text] [Related]
10. Screening for mutations of 21-hydroxylase gene in Hungarian patients with congenital adrenal hyperplasia.
Ferenczi A; Garami M; Kiss E; Pék M; Sasvári-Székely M; Barta C; Staub M; Sólyom J; Fekete G
J Clin Endocrinol Metab; 1999 Jul; 84(7):2369-72. PubMed ID: 10404805
[TBL] [Abstract][Full Text] [Related]
11. [Health status of adults with congenital adrenal hyperplasia due to 21-hydroxylase deficiency].
Bachelot A; Touraine P
Presse Med; 2014 Apr; 43(4 Pt 1):428-37. PubMed ID: 24630263
[TBL] [Abstract][Full Text] [Related]
12. Clinical and hormonal characteristics in heterozygote carriers of congenital adrenal hyperplasia.
Guarnotta V; Niceta M; Bono M; Marchese S; Fabiano C; Indelicato S; Di Gaudio F; Garofalo P; Giordano C
J Steroid Biochem Mol Biol; 2020 Apr; 198():105554. PubMed ID: 31805392
[TBL] [Abstract][Full Text] [Related]
13. Detection and assignment of CYP21 mutations using peptide mass signature genotyping.
Zeng X; Witchel SF; Dobrowolski SF; Moulder PV; Jarvik JW; Telmer CA
Mol Genet Metab; 2004 May; 82(1):38-47. PubMed ID: 15110320
[TBL] [Abstract][Full Text] [Related]
14. Molecular CYP21A2 diagnosis in 480 Brazilian patients with congenital adrenal hyperplasia before newborn screening introduction.
de Carvalho DF; Miranda MC; Gomes LG; Madureira G; Marcondes JA; Billerbeck AE; Rodrigues AS; Presti PF; Kuperman H; Damiani D; Mendonca BB; Bachega TA
Eur J Endocrinol; 2016 Aug; 175(2):107-16. PubMed ID: 27185867
[TBL] [Abstract][Full Text] [Related]
15. Fluorescent PCR and automated fragment analysis in preimplantation genetic diagnosis for 21-hydroxylase deficiency in congenital adrenal hyperplasia.
Van de Velde H; Sermon K; De Vos A; Lissens W; Joris H; Vandervorst M; Van Steirteghem A; Liebaers I
Mol Hum Reprod; 1999 Jul; 5(7):691-6. PubMed ID: 10381826
[TBL] [Abstract][Full Text] [Related]
16. The relation between two polymorphisms in the glucocorticoid receptor gene and body mass index, blood pressure and cholesterol in obese patients.
Di Blasio AM; van Rossum EF; Maestrini S; Berselli ME; Tagliaferri M; Podestà F; Koper JW; Liuzzi A; Lamberts SW
Clin Endocrinol (Oxf); 2003 Jul; 59(1):68-74. PubMed ID: 12807506
[TBL] [Abstract][Full Text] [Related]
17. The spectrum of clinical, hormonal and molecular findings in 280 individuals with nonclassical congenital adrenal hyperplasia caused by mutations of the CYP21A2 gene.
Livadas S; Dracopoulou M; Dastamani A; Sertedaki A; Maniati-Christidi M; Magiakou AM; Kanaka-Gantenbein C; Chrousos GP; Dacou-Voutetakis C
Clin Endocrinol (Oxf); 2015 Apr; 82(4):543-9. PubMed ID: 25041270
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in the diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Forest MG
Hum Reprod Update; 2004; 10(6):469-85. PubMed ID: 15514016
[TBL] [Abstract][Full Text] [Related]
19. An update of congenital adrenal hyperplasia.
New MI
Ann N Y Acad Sci; 2004 Dec; 1038():14-43. PubMed ID: 15838095
[TBL] [Abstract][Full Text] [Related]
20. A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo.
Huizenga NA; Koper JW; De Lange P; Pols HA; Stolk RP; Burger H; Grobbee DE; Brinkmann AO; De Jong FH; Lamberts SW
J Clin Endocrinol Metab; 1998 Jan; 83(1):144-51. PubMed ID: 9435432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
